Pulsenmore Ltd. (TLV: PULS)
Israel
· Delayed Price · Currency is ILS · Price in ILA 453.20
+52.10 (12.99%)
Jan 19, 2025, 3:49 PM IDT
Pulsenmore Market Cap
Pulsenmore has a market cap or net worth of 215.79 million as of January 22, 2025. Its market cap has decreased by -38.24% in one year.
Market Cap
215.79M
Enterprise Value
98.12M
Revenue
8.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
453.20
Market Cap Chart
Since June 15, 2021, Pulsenmore's market cap has decreased from 795.01M to 215.79M, a decrease of -72.86%. That is a compound annual growth rate of -30.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 215.79M | -14.24% |
| Dec 31, 2024 | 251.62M | -29.08% |
| Dec 31, 2023 | 354.81M | -4.28% |
| Dec 29, 2022 | 370.68M | -42.16% |
| Dec 30, 2021 | 640.93M | -19.38% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 88.56B |
| Danel (Adir Yeoshua) | 2.55B |
| Kamada | 1.46B |
| Bait Bakfar | 1.05B |
| Novolog (Pharm-Up 1966) | 965.26M |
| Ilex Medical | 817.17M |
| BrainsWay | 690.44M |
| SofWave Medical | 603.16M |